Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongxiang Zhang

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Oncotarget|October 21, 2016
Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophagesYang Yu, Qingyun Zhang, Qinggui Meng, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 1, 2026
Harnessing Corrosion in A P(VDF-TrFE)/Mg Composite for Dynamic Passivation and OsteoimmunomodulationWeiwei Lao, Yanyan Li, Hongxiang Zhang, et al.
Molecular Plant|September 30, 2020
A 2-kb Mycovirus Converts a Pathogenic Fungus into a Beneficial Endophyte for Brassica Protection and Yield EnhancementHongxiang Zhang, Jiatao Xie, Yanping Fu, et al.
Plant Biotechnology Journal|July 15, 2021
Editing homologous copies of an essential gene affords crop resistance against two cosmopolitan necrotrophic pathogensXuekun Zhang, Jiasen Cheng, Yang Lin, et al.
Lipids|June 26, 2012
Isolation of a Δ5 desaturase gene from Euglena gracilis and functional dissection of its HPGG and HDASH motifsDana Walters Pollak, Michael W Bostick, Hyeryoung Yoon, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular Cancer Therapeutics|January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant CancersLauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Molecular Cancer Therapeutics|October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in CancerAntoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Cancer Research|June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy EfficacyAlvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Oncotarget|October 21, 2016
Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophagesYang Yu, Qingyun Zhang, Qinggui Meng, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 1, 2026
Harnessing Corrosion in A P(VDF-TrFE)/Mg Composite for Dynamic Passivation and OsteoimmunomodulationWeiwei Lao, Yanyan Li, Hongxiang Zhang, et al.
Molecular Plant|September 30, 2020
A 2-kb Mycovirus Converts a Pathogenic Fungus into a Beneficial Endophyte for Brassica Protection and Yield EnhancementHongxiang Zhang, Jiatao Xie, Yanping Fu, et al.
Plant Biotechnology Journal|July 15, 2021
Editing homologous copies of an essential gene affords crop resistance against two cosmopolitan necrotrophic pathogensXuekun Zhang, Jiasen Cheng, Yang Lin, et al.
Lipids|June 26, 2012
Isolation of a Δ5 desaturase gene from Euglena gracilis and functional dissection of its HPGG and HDASH motifsDana Walters Pollak, Michael W Bostick, Hyeryoung Yoon, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular Cancer Therapeutics|January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant CancersLauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 16, 2025
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Matthew R Tonini, Lauren Catherine M Martires, et al.
Molecular Cancer Therapeutics|October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in CancerAntoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Cancer Research|June 10, 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Anti-Tumor Immunity and Immunotherapy EfficacyAlvin Ziying Lu, Brian B Haines, Wenhai Zhang, et al.
Pageof 11